| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Hematologic malignancy
Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma
Do Young Kim, Jehyun Nam, Joo-seop Chung, Sang-Woo Kim, Ho-Jin Shin
Cancer Res Treat. 2022;54(1):301-313.   Published online April 27, 2021    DOI: https://doi.org/10.4143/crt.2020.1371
                           Web of Science 2  Crossref 4
Primary Histiocytic Sarcoma of the Central Nervous System
Hoonsub So, Sun A Kim, Dok Hyun Yoon, Shin Kwang Khang, Jihye Hwang, Chong Hyun Suh, Cheolwon Suh
Cancer Res Treat. 2015;47(2):322-328.   Published online August 29, 2014    DOI: https://doi.org/10.4143/crt.2013.163
                           Web of Science 16  Crossref 16
Intrapleural Chemotherapy with Cisplatin and Cytarabine in the Management of Malignant Pleural Effusion
Kee Won Kim, Suk Young Park, Myung Sook Kim, Seok Chan Kim, Eun Hee Lee, So Young Shin, Jong Ho Lee, Jong Bum Kweon, Kuhn Park
Cancer Res Treat. 2004;36(1):68-71.   Published online February 29, 2004    DOI: https://doi.org/10.4143/crt.2004.36.1.68
                           Crossref 7
Prognostic Implications of Cytarabine Dose in Consolidation Chemotherapy for the Patients with Acute Myelogenous Leukemia
Jung Hee Lee, Je Hwan Lee, Kyoo Hyung Lee, Hyeseung Bahng, Jin Hee Ahn, Jung Shin Lee, Sang Hee Kim, Woo Kun Kim
J Korean Cancer Assoc. 2000;32(5):954-961.
      
Treatment of Relapsed ro Refractory Acute leukemia with High / Intermediate - dose Cytarabine and Idarubicin
Seong Chul Kim, Yoo Hong Min, Hyun Jin Noh, Seung Tae Lee, Bo Yong Chung, Jee Sook Hahn, Yun Woong Ko
J Korean Cancer Assoc. 1996;28(2):301-308.
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Journal Impact Factor 4.6
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI